This drug has the potential to be more targeted than others currently being studied, and we hope it will result in fewer ...
The drug is RI-AG03, and it's a peptide inhibitor (a blocker of proteins). In tests on fruit flies and human cells, it has ...
AG03, targets two key areas of the Tau protein in Alzheimer's disease, showing effectiveness in lab and fruit fly models.
The increasing knowledge on how protein tau is organized in live cells has shown that the protein forms nanometer-sized ...
Scientists have developed a drug that targets both major aggregation-promoting sites of the Tau protein, a key player in ...
A new drug targeting Tau protein shows promise in preventing its accumulation, potentially leading to more effective ...
An international team of researchers has made a significant breakthrough in Alzheimer's drug development with the ...
RESEARCHERS have developed a drug that successfully blocks two major Alzheimer’s disease “hotspots” at once, in a “promising” breakthrough against the brain robbing ...
An international team of researchers led by Lancaster University has made a promising breakthrough in the development of ...